Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes

NCT00274274 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
373
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S